A study author is based in Johns Hopkins School of Medicine, and the research is connected to Baltimore, now involving the FDA for drug approval.
1 report, 1 independent
Updated Sep 17
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A study author is based in Johns Hopkins School of Medicine, and the research is connected to Baltimore, now involving the FDA for drug approval.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
Baltimore
city in Maryland, United States
-
Johns Hopkins School of Medicine
academic medical teaching and research arm of Johns Hopkins University
Nothing else this week.
Related events
- A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.
- Both the FDA and the European Medicines Agency govern drug approval processes.
- Eli Lilly and Company plans to submit a drug candidate to the FDA for review and approval.
- The FDA has not approved a drug for market, and expert practice related to the drug is based in New York.
- A Patient Assistance Program has been established to cover prescription medications that have received FDA approval.